GGrantIndex
← Leaderboards

David J Segal

University Of Arizona

Google Scholar ↗PubMed ↗ORCID ↗
$11,396,189
Attributed
$12,516,235
Total exposure
13
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $5.8M · FY2006–25
$10M$7.5M$5M$2.5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$30,782,991 · 15

By mechanism

U42$23,857,607 · 4
R21$3,055,638 · 7
R01$2,470,958 · 2
UH3$935,357 · 1
UH2$463,431 · 1

Top collaborators

Most similar at University Of Arizona

Same institution · by research overlap

Others in their field

Top investigators on “Human Disease”

Research focus

Human DiseaseTechnologyGenome EditingTranslationsGenomeSpecificityBaseSomatic Cell Gene EditingResearch PersonnelEvaluationResourcesInfrastructureNonhuman PrimateCellsFutureEnsureIn VivoReporterCenter For Translational Science ActivitiesCaliforniaPrimatesSafetyCollaborationsClinical Sciences

Grant awards (54)

Center for Somatic Cell Genome Editing in Nonhuman Primates$1,341,300
U42 · FY2025 · OD
Genome Editing and Biological Effects Testing Component$651,851
U42 · FY2025 · OD · contact PI
ASO Therapy for ADNP$395,009
R21 · FY2025 · NS · contact PI
Center for Somatic Cell Genome Editing in Nonhuman Primates$1,341,300
U42 · FY2024 · OD
Genome Editing and Biological Effects Testing Component$651,851
U42 · FY2024 · OD · contact PI
Nonhuman Primate Testing Center for Evaluation of Somatic Cell Genome Editing Tools$2,161,860
U42 · FY2023 · OD
Center for Somatic Cell Genome Editing in Nonhuman Primates$1,341,300
U42 · FY2023 · OD
Genome Editing Testing Core$937,871
U42 · FY2023 · OD · contact PI
Genome Editing and Biological Effects Testing Component$651,851
U42 · FY2023 · OD · contact PI
Nonhuman Primate Testing Center for Evaluation of Somatic Cell Genome Editing Tools: Antibodies Supplement$241,224
U42 · FY2023 · OD
Nonhuman Primate Testing Center for Evaluation of Somatic Cell Genome Editing Tools$2,551,595
U42 · FY2022 · OD
Genome Editing Testing Core$1,043,797
U42 · FY2022 · OD · contact PI
LATC Collaborative Projects$1,002,488
U42 · FY2022 · OD
Innovative Translational Imaging Technologies to Monitor Genome Edited Cells in Vivo$471,313
UH3 · FY2022 · EB
LATC Collaborative Project$365,885
U42 · FY2022 · OD
The Epigenetics Crossroads of Environmental Exposures and Early-Life Adversity$189,363
R21 · FY2022 · ES · contact PI
SCGE Administrative Supplement$187,405
U42 · FY2022 · OD
Nonhuman Primate Testing Center for Evaluation of Somatic Cell Genome Editing Tools$2,161,860
U42 · FY2021 · OD
LATC Collaborative Projects$1,057,357
U42 · FY2021 · OD
Genome Editing Testing Core$983,875
U42 · FY2021 · OD · contact PI
Innovative Translational Imaging Technologies to Monitor Genome Edited Cells in Vivo$464,044
UH3 · FY2021 · EB
SCGE Comparative Studies Supplement$327,913
U42 · FY2021 · OD
The Epigenetics Crossroads of Environmental Exposures and Early-Life Adversity$227,342
R21 · FY2021 · ES · contact PI
Nonhuman Primate Testing Center for Evaluation of Somatic Cell Genome Editing Tools: Equipment Supplement$97,171
U42 · FY2021 · OD
Nonhuman Primate Testing Center for Evaluation of Somatic Cell Genome Editing Tools$1,161,374
U42 · FY2020 · OD
Nonhuman Primate Testing Center for Evaluation of Somatic Cell Genome Editing Tools$572,152
U42 · FY2020 · OD
Genome Editing Testing Core$336,248
U42 · FY2020 · OD · contact PI
Innovative Translational Imaging Technologies to Monitor Genome Edited Cells in Vivo$227,939
UH2 · FY2020 · EB
Determinants of Persistence in Epigenetic Editing$187,240
R21 · FY2020 · HG · contact PI
Nonhuman Primate Testing Center for Evaluation of Somatic Cell Genome Editing Tools$1,185,829
U42 · FY2019 · OD
Nonhuman Primate Testing Center for Evaluation of Somatic Cell Genome Editing Tools$1,168,743
U42 · FY2019 · OD
Genome Editing Testing Core$333,507
U42 · FY2019 · OD · contact PI
Innovative Translational Imaging Technologies to Monitor Genome Edited Cells in Vivo$235,492
UH2 · FY2019 · EB
Precision Nonhuman Primate Models for Congenital Diseases$231,600
R21 · FY2019 · NS
Determinants of Persistence in Epigenetic Editing$227,309
R21 · FY2019 · HG · contact PI
Precision Nonhuman Primate Models for Congenital Diseases$193,000
R21 · FY2018 · NS
CRISPR-based epigenetic modifiers$316,300
R21 · FY2017 · CA · contact PI
CRISPR-based epigenetic modifiers$68,539
R21 · FY2017 · CA · contact PI
CRISPR-based epigenetic modifier$23,142
R21 · FY2017 · CA · contact PI
CRISPR-based epigenetic modifiers$324,050
R21 · FY2016 · CA · contact PI
NextGen DNA Binding Proteins Based on TAL Domains$277,529
R01 · FY2014 · GM · contact PI
NextGen DNA Binding Proteins Based on TAL Domains$268,664
R01 · FY2013 · GM · contact PI
NextGen DNA Binding Proteins Based on TAL Domains$279,465
R01 · FY2012 · GM · contact PI
NextGen DNA Binding Proteins Based on TAL Domains$269,102
R01 · FY2011 · GM · contact PI
Towards Gene Therapy for Angelman Syndrome$212,492
R21 · FY2011 · NS · contact PI
SEER - a novel method for the detection of genetic sequences$268,476
R01 · FY2010 · GM · contact PI
Towards Gene Therapy for Angelman Syndrome$179,052
R21 · FY2010 · NS · contact PI
SEER - a novel method for the detection of genetic sequences$271,445
R01 · FY2009 · GM · contact PI
SEER - a novel method for the detection of genetic sequences$271,687
R01 · FY2008 · GM · contact PI
SEER - a novel method for the detection of genetic sequences$271,882
R01 · FY2007 · GM · contact PI
SEER - a novel method for the detection of genetic sequences$292,708
R01 · FY2006 · GM · contact PI
Inactivation of HIV by in vivo genetic modification$110,755
R21 · FY2004 · CA
Inactivation of HIV by in vivo genetic modification$29,645
R21 · FY2004 · CA
Inactivation of HIV by in vivo genetic modification$140,800
R21 · FY2003 · CA